跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,210 条关于
“BCR-ABL1 kinase”
全部
6,210
临床试验
3,340
药物
935
机构
40
资讯
1,895
去年
FDA Grants Accelerated Approval to Asciminib for Newly Diagnosed Chronic Myeloid Leukemia
去年
Novartis Receives CDSCO Approval for Phase IIIb Trial of Asciminib in Chronic Myeloid Leukemia
去年
FDA Approves Scemblix (asciminib) for First-Line Treatment of Chronic Myelogenous Leukemia
2年前
Triplet Therapy Shows Promise in Advanced Chronic Myeloid Leukemia
5个月前
Flumatinib Therapeutic Drug Monitoring Reveals Key Exposure Thresholds for Molecular Response in Chinese CML-CP Patients
去年
SOHO 2024: Advancements in ALL, CML, and CLL Treatment Strategies
去年
FDA Approves Asciminib (Scemblix) as First-Line Treatment for Ph+ CML-CP
去年
ImmunoForge's Pemziviptadil Receives FDA IND Approval for Phase 2 DMD Cardiomyopathy Trial
6个月前
Digital PCR Outperforms Standard RT-qPCR in Detecting Residual BCR::ABL1 in CML Patients, Enabling Better TKI Discontinuation Decisions
去年
Ascentage Pharma Reports Strong Growth with 93% Increase in Olverembatinib Sales and Historic Lisaftoclax Approval
第 1 页,共 190 页
上一页
下一页